Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis
about
Gene expression analysis in RA: towards personalized medicineAnti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasomeA novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab.Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease.Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patientsCurrent and future trends in biomarker discovery and development of companion diagnostics for arthritis.Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis.Modular analysis of peripheral blood gene expression in rheumatoid arthritis captures reproducible gene expression changes in tumor necrosis factor responders.Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile.Is there a role of synovial biopsy in drug development?T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samples.Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study.Ulcerative colitis: prevention of relapse.Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases.Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis.Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.Transcriptional profiling of leukocytes from rheumatoid arthritis patients before and after anti-tumor necrosis factor therapy: A comparison of anti-nuclear antibody positive and negative subsets.Circulating Biomarkers for Predicting Infliximab Response in Rheumatoid Arthritis: A Systematic Bioinformatics Analysis.Moving towards personalized medicine in rheumatoid arthritis.Theory of signs and statistical approach to big data in assessing the relevance of clinical biomarkers of inflammation and oxidative stress.Pharmacogenomics in rheumatoid arthritis: how close are we to the clinic?Prediction of Therapeutic Responses to Tocilizumab in Patients With Rheumatoid Arthritis: Biomarkers Identified by Analysis of Gene Expression in Peripheral Blood Mononuclear Cells Using Genome-Wide DNA Microarray
P2860
Q26825706-18B20DAF-30F6-43C0-9260-53DD23ADB95BQ28540052-7E331D52-9AC5-4014-8133-C4873F1858E7Q31090628-32619B18-88C2-46CE-92CB-52EED16D984EQ33730446-FCCBC1F6-4AE8-44AE-AFAB-D0833BC19E67Q33781056-34BB2818-CD44-4E33-A95A-318FA3F0B2F8Q34688901-B392DC91-B727-45F4-B58D-920B5E1ECCE7Q35470652-1E0DC14D-279A-4F66-AC1C-36DC7BA4DCA0Q35650155-34D7DA61-D06B-451D-99C1-1C25166D69F5Q35766221-A9E201DB-0BEB-4688-81FD-46046B8771D3Q35963141-EB9DC259-716A-49C5-8B23-B111864CB513Q35994130-3B3DDEA4-8151-421F-82DD-A4E126BDC1F9Q36215165-61D03E73-11E5-46E7-9835-BCF5C808AD54Q36439978-6EFCA69F-5649-4D50-A2D4-297648AF5B98Q37256337-AA90DAD4-7C7C-4153-AC46-AE7C3DF6B45DQ38103628-EFE33BED-8DBE-4345-A422-A9E5A8F891C2Q38286234-5BD8BD13-F9A2-4B1F-9B84-2973CAFB188BQ38529234-354E7CDD-E215-4D88-B9D3-24C25DD81380Q38797638-F53ADFC1-C2B5-42B2-ADB2-67B16B8A38E2Q42247134-12A70B1B-C66B-45B5-A996-CC716B221A87Q42290532-D26F7256-DB88-420E-9A81-B128C784302AQ42699496-07731CDA-0356-4B7A-83C7-432E3DAAF325Q49790693-8DCAC8E1-469C-44EB-B3A0-44684A9B0B2DQ52839030-D605B590-8191-4C04-8EAF-968BABAB2D5CQ58412739-ACA6449A-581F-4C9D-B2EE-8293A7D7C45A
P2860
Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Validation study of existing g ...... ents with rheumatoid arthritis
@ast
Validation study of existing g ...... ents with rheumatoid arthritis
@en
Validation study of existing g ...... ents with rheumatoid arthritis
@nl
type
label
Validation study of existing g ...... ents with rheumatoid arthritis
@ast
Validation study of existing g ...... ents with rheumatoid arthritis
@en
Validation study of existing g ...... ents with rheumatoid arthritis
@nl
prefLabel
Validation study of existing g ...... ents with rheumatoid arthritis
@ast
Validation study of existing g ...... ents with rheumatoid arthritis
@en
Validation study of existing g ...... ents with rheumatoid arthritis
@nl
P2093
P2860
P50
P1433
P1476
Validation study of existing g ...... ents with rheumatoid arthritis
@en
P2093
Agnes M Eijsbouts
Marieke J H Coenen
Piet L C M van Riel
Pilar Barrera
Simon V van Reijmersdal
Timothy R D J Radstake
Wietske Kievit
P2860
P304
P356
10.1371/JOURNAL.PONE.0033199
P407
P577
2012-03-21T00:00:00Z